USCOM LIMITED — Board/Management Information 2011

Sep 15, 2011

Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au

M A R K E T A N N O U N C E M E N T

Appointment of new CEO

Friday 16th of September 2011: Uscom (ASX code: UCM).

Uscom announces today that Mr. Joe Trygar has been appointed Chief Executive Officer of the company.

Mr. Trygar is based in North America and has been with the company since July 2011 when he joined as SVP of Sales. His promotion to CEO comes at a time when the company needs to start improving the support to its new distributors and develop partnerships that will enhance the effectiveness of our global channels strategy in generating sales.

Mr. Trygar joins Uscom with more than 30 years experience in the medical instrumentation and automation markets including research, engineering, strategic development, & global distribution. He has effectively turned around several small to mid sized companies, launched innovative products into new markets, and has combined a successful entrepreneurial career with equal success with Fortune 500 companies.

Executive Chairman of Uscom, Phil Kiely said, “We have put much effort into building a global distribution network and now need to develop sound strategies to capitalize on these relationships. We also need to develop a coordinated approach across our entire channel initiatives and production capabilities and Joe is the right person to achieve this. Joe is recognized for his ability to distill complex issues to fundamentals, create blueprints for growth, & implement systems & initiatives to grow sales revenues, profitability, sustainability, competitive advantage, & high close ratios.”

Mr. Kiely said,” We have barely scratched the surface of the US$2.8b revenues generated in the cardiac patient monitor market and Mr. Trygar’s pivotal appointment at this time will help Uscom secure its fair share of this rapidly expanding marketplace”.

Mr Trygar said,” I fully believe in Uscom’s unique technology and with the right execution plan we can become a market leader in this space. I bring a wealth of knowledge and contacts in the medical device industry to Uscom and am already in the process of implementing a comprehensive plan to achieve sales growth with sustainability.”

Mr Rob Phillips, the company founder, will continue in the role of Chief Science Officer.

About Uscom

Uscom Limited is an Australian medical device company which was first listed on the Australian Stock Exchange in December 2003. Uscom has developed a Non Invasive Cardiac Output Monitor. The USCOM is a simple, cost-effective and non-invasive device that measures heart function, detects irregularities and guides treatment. The USCOM device has major applications in Paediatrics, Emergency Medicine, Intensive Care Units and Anesthesia, and is a tool of choice for management of adult and paediatric sepsis, and for the guidance of all fluid administration. USCOM has global regulatory approval and the technology is currently marketed in North America, South America, Europe, the Middle East, India, Australia & New Zealand. China and SE Asia.

Uscom Contacts Phil Kiely Executive Chairman phil.kiely@uscom.com.au

Daniel Fah Company Secretary daniel.fah@uscom.com.au